Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice

被引:42
作者
Rossetti, L [1 ]
Barzilai, N [1 ]
Chen, W [1 ]
Harris, T [1 ]
Yang, D [1 ]
Rogler, CE [1 ]
机构
[1] ALBERT EINSTEIN COLL MED,LIVER RES CTR,BRONX,NY 10461
关键词
D O I
10.1074/jbc.271.1.203
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The physiological role of circulating insulin-like growth factor-II (IGF-II) in adult humans is poorly understood, We recently generated an IGF-II transgenic murine model of persistent IGF-II production (plasma IGF-II similar to 30-fold increased above normal) through overexpression of the transgene driven by the major urinary protein promoter (Rinderknecht, E., and Humbel, R. E. (1978) J. Biol. Chem. 269, 13779-13784), To determine whether in vivo insulin action is improved in these transgenic mice, we performed euglycemic insulin (18 milliunits/kg . min) clamp studies in conscious IGF II transgenic and in age- and weight-matched control mice, Plasma glucose and insulin concentrations were significantly lower in the IGF-II transgenic compared with both control groups, Despite decreased plasma glucose concentration, basal hepatic glucose production (HGP) and glucose clearance were increased. During the insulin clamp studies in IGF-II transgenic mice compared with control mice (a) the rates of glucose infusion and glucose uptake were increased by similar to 65 and similar to 55%, respectively; (b) glycolysis was increased by similar to 12% while glycogen synthesis was similar to 2-fold higher; (c) while the suppression of plasma free fatty acid was similar, the increment in plasma lactate concentration was significantly higher; (d) although HGP was similarly inhibited by insulin, phosphoenolpyruvate gluconeogenesis was enhanced and accounted for a larger portion of HGP (64% versus similar to 40% in control mice). Our data suggest that the persistence of circulating IGF-II in adult mice to levels commonly observed in adult humans (50-70 nM) causes a marked improvement in peripheral (skeletal muscle) insulin action, which is not due to changes in body composition, These results suggest that circulating IGF-II may exert a regulatory role on insulin sensitivity and body composition in humans.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 34 条
  • [1] DEVELOPMENTAL PATTERNS OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II SYNTHESIS AND REGULATION IN RAT FIBROBLASTS
    ADAMS, SO
    NISSLEY, SP
    HANWERGER, S
    RECHLER, MM
    [J]. NATURE, 1983, 302 (5904) : 150 - 153
  • [2] BARZILAI N, 1993, J BIOL CHEM, V268, P25019
  • [3] INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II - AGING AND BONE-DENSITY IN WOMEN
    BENNETT, AE
    WAHNER, HW
    RIGGS, BL
    HINTZ, RL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (04) : 701 - 704
  • [4] STIMULATION OF GLUCOSE-UPTAKE BY INSULIN-LIKE GROWTH-FACTOR-II IN HUMAN MUSCLE IS NOT MEDIATED BY THE INSULIN-LIKE GROWTH-FACTOR-II MANNOSE 6-PHOSPHATE RECEPTOR
    BURGUERA, B
    ELTON, CW
    TAPSCOTT, EB
    PORIES, WJ
    DIMARCHI, R
    SAKANO, KI
    DOHM, GL
    [J]. BIOCHEMICAL JOURNAL, 1994, 300 : 781 - 785
  • [5] INSULIN-LIKE GROWTH FACTOR-I BINDING IN HEPATOCYTES FROM HUMAN-LIVER, HUMAN HEPATOMA, AND NORMAL, REGENERATING, AND FETAL-RAT LIVER
    CARO, JF
    POULOS, J
    ITTOOP, O
    PORIES, WJ
    FLICKINGER, EG
    SINHA, MK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (04) : 976 - 981
  • [6] INSULIN-LIKE GROWTH-FACTORS (IGFS) - IMPLICATIONS FOR AGING
    COHEN, P
    OCRANT, I
    FIELDER, PJ
    NEELY, EK
    GARGOSKY, SE
    DEAL, CI
    CEDA, GP
    YOUNGMAN, O
    PHAM, H
    LAMSON, G
    GIUDICE, LC
    ROSENFELD, RG
    [J]. PSYCHONEUROENDOCRINOLOGY, 1992, 17 (04) : 335 - 342
  • [7] GLUCOSE COUNTERREGULATION - PREVENTION AND CORRECTION OF HYPOGLYCEMIA IN HUMANS
    CRYER, PE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02): : E149 - E155
  • [8] SIGNAL TRANSMISSION BY THE INSULIN-LIKE GROWTH-FACTORS
    CZECH, MP
    [J]. CELL, 1989, 59 (02) : 235 - 238
  • [9] INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II - PEPTIDE, MESSENGER RIBONUCLEIC-ACID AND GENE STRUCTURES, SERUM, AND TISSUE CONCENTRATIONS
    DAUGHADAY, WH
    ROTWEIN, P
    [J]. ENDOCRINE REVIEWS, 1989, 10 (01) : 68 - 91
  • [10] A GROWTH-DEFICIENCY PHENOTYPE IN HETEROZYGOUS MICE CARRYING AN INSULIN-LIKE GROWTH FACTOR-II GENE DISRUPTED BY TARGETING
    DECHIARA, TM
    EFSTRATIADIS, A
    ROBERTSON, EJ
    [J]. NATURE, 1990, 345 (6270) : 78 - 80